Federal Register #2026-22328

OMB RFI on Domestic and Near-Shore Essential Medicines Manufacturing Capabilities

The Office of Management and Budget (OMB) is seeking information on idle essential-medicines manufacturing capacity in the United States and near-shore locations. - Government buyer: Office of Management and Budget (OMB); the request concerns medicines associated with the Administration for Strategic Preparedness and Response (ASPR) 86 List. - Request: Information about new and unused (idle) manufacturing capabilities for Finished Dose Forms, Active Pharmaceutical Ingredients, and Key Starting Materials. - OEMs and vendors: None named. - Products, quantities, and part numbers: No specific products, quantities, or part numbers are requested; this is a capabilities-focused RFI. - Notable requirements: Responses are voluntary. The notice does not commit the government to make a purchase or reimburse respondents.

Description

The Office of Management and Budget (OMB) is reopening the response period for an RFI about new and unused domestic, U.S.-based, and near-shore production capabilities for Finished Dose Forms, Active Pharmaceutical Ingredients, and Key Starting Materials associated with the ASPR 86 List of essential medicines. The original response period closed on October 26, 2026. Responses must be submitted electronically through regulations.gov by November 27, 2026. Participation is voluntary, and the notice does not constitute a government commitment to pay for or reimburse respondents.

View original listing